Filed in archive
Research
, Treatment
by Gloria Gamat on September 19, 2007
Metformin - commercially available as Glucophage - is a popular diabetes drug that works by making the body more responsive to insulin. On the other hand, sitagliptin or the Merck diabetes drug Januvia™ works to boost the body's ability to lower elevated blood sugar levels.
When combined together in people with type 2 diabetes, sitagliptin and metformin improves blood sugar control in a synergistic fashion, according to a new study by Merck Research Laboratories.
Find more details from Merck News.

When combined together in people with type 2 diabetes, sitagliptin and metformin improves blood sugar control in a synergistic fashion, according to a new study by Merck Research Laboratories.
"This was significantly better than results with a single drug and "demonstrated an additive response."
There was a low incidence of hypoglycemia, or low blood sugar, which was not significantly different from that in the placebo group.
This study shows that the combination of sitagliptin and metformin provides "substantial and additive" improvement in blood sugar levels and is "generally well tolerated."
Find more details from Merck News.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/92460
Mr Wong
Vote for Sitagliptin-Metformin Combo, Synergistically Works Against Type 2 Diabetes:
|
Rating: 7.14 out of 7 vote(s) cast.
|
Response from:
Anissa
(10/31/07 9:48am)
There is a mistake in this article. Metforim is commercially available as Glucophage and NOT Actos. Actos is the brand name for pioglitazone - a completely different class of oral antidiabetic to metformin. Suggest amendment before anyone makes a mistake and sues!
Response from:
Gloria
(10/31/07 7:22pm)
amended. thanks for the heads up! ;-)
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |









